Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 3Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 70Breast Neoplasms 64Neoplasms 35Carcinoma, Non-Small-Cell Lung 29Neoplasm Metastasis 20Triple Negative Breast Neoplasms 18Lung Neoplasms 13Ovarian Neoplasms 12Adenocarcinoma 12Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Melanoma 10Head and Neck Neoplasms 8Fallopian Tube Neoplasms 7Cholangiocarcinoma 7Urinary Bladder Neoplasms 6Recurrence 6Esophageal Neoplasms 6Digestive System Neoplasms 5Colorectal Neoplasms 5Carcinoma, Ovarian Epithelial 5Uterine Cervical Neoplasms 4Sarcoma, Ewing 4Sarcoma 4Prostatic Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Diseases 4Inflammatory Breast Neoplasms 4Gallbladder Neoplasms 4Endocrine Gland Neoplasms 4

Interventions

Gemcitabine 7130-nm albumin-bound paclitaxel 5Fluorouracil 3Albumin-Bound Paclitaxel 3dehydroftorafur 2Taxes 2Oxaliplatin 2tocilizumab 1selicrelumab 1niraparib 1cobimetinib 1atezolizumab 1Tiragolumab 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pancreatectomy 1PEGPH20 1Nivolumab 1Leucovorin 1Irinotecan 1Ipilimumab 1Interleukin 1 Receptor Antagonist Protein 1Erlotinib Hydrochloride 1Electronic Health Records 1Cisplatin 1Bevacizumab 14-fluorobenzoyl-TN-14003 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Pancreatic Adenocarcinoma × Albumin-Bound Paclitaxel × Clear all
NCT02427841 2023-09-06

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 17 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Completed
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡